Cargando…
Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
BACKGROUND: Convalescent plasma, widely utilized in viral infections that induce neutralizing antibodies, has been proposed for COVID-19, and preliminary evidence shows that it might have beneficial effect. Our objective was to determine the risk factors for 28-days mortality in patients who receive...
Autores principales: | Salazar, Martín R., González, Soledad E., Regairaz, Lorena, Ferrando, Noelia S., González Martínez, Verónica V., Carrera Ramos, Patricia M., Muñoz, Laura, Pesci, Santiago A., Vidal, Juan M., Kreplak, Nicolás, Estenssoro, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084206/ https://www.ncbi.nlm.nih.gov/pubmed/33914780 http://dx.doi.org/10.1371/journal.pone.0250386 |
Ejemplares similares
-
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
por: González, Soledad, et al.
Publicado: (2022) -
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study
por: González, Soledad, et al.
Publicado: (2023) -
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina
por: González, Soledad, et al.
Publicado: (2021) -
Convalescent plasma for administration of passive antibodies against viral agents
por: Di Minno, Giovanni, et al.
Publicado: (2020) -
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
por: Bloch, Evan M., et al.
Publicado: (2022)